Headed by a strong pool of scientists and researchers, R & D activities are at the core of Intas. Our constant quest for developing new products and technology has led to us to make breakthrough innovations in a wide spectrum of research areas.

At Intas, innovation is the way of life. Intas was amongst the first companies to introduce new drug delivery systems in its formulations (like melt-in-mouth technology for Domperidone, sustained release in Alprazolam, once daily dosage for Isosorbide 5-Mono Nitrate and controlled release Sodium Valprolate).

Intas is currently engaged in creating API capabilities for the niche therapeutic segments in the areas of anticancer agents, oral formulations, NDDS and control drug delivery mechanisms.